Biotech & AI drug discoveryNature Biotechnology

An engineered, compact Cas12m variant for multiplexed gene activation in vivo

Nature Biotechnology reports an engineered, compact Cas12m variant intended for multiplexed gene activation in vivo. No further details are provided in the supplied material.

AI summary · generated only from source feed metadata; consult original

Source published2026-10-28T00:00:00+00:00

Published here2026-10-29T15:59:31+00:00

Original source

Nature Biotechnology

Media report · consult original reporting

Read the original ↗https://www.nature.com/articles/s41587-026-03352-5

Original headline

An engineered, compact Cas12m variant for multiplexed gene activation in vivo

AI bilingual edit · consult original

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.